Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis

A. K. Salahudeen, R. Wilkinson, J. McAinsh, D. N. Bateman

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

The elimination of atenolol (20 mg i.v.) has been studied in seven patients with renal failure on continuous ambulatory peritoneal dialysis (CAPD). Although atenolol was eliminated in the peritoneal fluid, the amount recovered in 24 h was relatively low (1.2 ± 0.15 mg). The calculated urinary (n=4) and peritoneal (n=7) clearance was 0.289 ± 0.058 l/h and 0.152 ± 0.018 l/h respectively. This was considerably less than calculated total body clearance (1.21 ± 0.086 l/h). The kinetics of atenolol in CAPD are worthy of further study.

Original languageEnglish (US)
Pages (from-to)457-460
Number of pages4
JournalBritish Journal of Clinical Pharmacology
Volume18
Issue number3
StatePublished - 1984

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis'. Together they form a unique fingerprint.

Cite this